Literature DB >> 3957623

Cerebrospinal fluid lymphocyte subpopulations in multiple sclerosis.

M G Marrosu, C Cianchetti, M G Ennas.   

Abstract

T3+ (all-T) and T8+ (suppressor/cytotoxic) cells were studied in cerebrospinal fluid (CSF) from 24 patients with multiple sclerosis (MS) and from 24 subjects with various "non-immunological" disease (NID). MS patients were classed as (a) during the acute phase of the 1st episode of the disease, (b) in acute relapse, (c) with chronic progressive disease, (d) with increased or (e) normal CSF IgG content or (f) with neurological impairment (Kurtzke scale) less than or equal to 3 or (g) greater than 3. In MS cases considered as a whole a significant decrease in CSF T3+ cells was found compared to NID patients. When single groups were considered, T3+ cells decrease was significant in classes (b), (d) and (f). Significantly lower percentages of T8+ cells, compared to NID, were found in MS classes (a), (d) and (f).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957623     DOI: 10.1007/bf02230426

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  24 in total

1.  Leukocyte surface antigens in patients with multiple sclerosis.

Authors:  E S Mingioli; D E McFarlin
Journal:  J Neuroimmunol       Date:  1984-04       Impact factor: 3.478

2.  Low T8 antigen density on lymphocytes in active multiple sclerosis.

Authors:  A T Reder; J P Antel; J J Oger; T A McFarland; M Rosenkoetter; B G Arnason
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

3.  Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns.

Authors:  D R Jacoby; M B Oldstone
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

4.  Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis.

Authors:  J Antel; J J Oger; S Jackevicius; H H Kuo; B G Arnason
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis.

Authors:  J Booss; M M Esiri; W W Tourtellotte; D Y Mason
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

6.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in multiple sclerosis.

Authors:  P E Manconi; M G Marrosu; C Cianchetti; M G Ennas; A Mangoni; D Zaccheo
Journal:  Acta Neurol Scand       Date:  1980-09       Impact factor: 3.209

8.  T-cell subsets in spinal fluid of multiple sclerosis patients.

Authors:  O R Hommes; C J Brinkman
Journal:  J Neuroimmunol       Date:  1984-04       Impact factor: 3.478

9.  Surface markers on lymphocytes from human cerebrospinal fluid. Identification by monoclonal antibodies.

Authors:  M G Marrosu; M G Ennas; M R Murru; G Marrosu; C Cianchetti; P E Manconi
Journal:  J Neuroimmunol       Date:  1983-12       Impact factor: 3.478

10.  Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; S M Friedman; P C Kung; G Goldstein; L Chess
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  1 in total

1.  Cerebrospinal fluid and peripheral blood T-lymphocyte subsets in multiple sclerosis: monoclonal antibody analysis and correlations with clinical activity.

Authors:  A Salmaggi; G Bianchi; D Cerrato; M Lazzaroni; L Malesani; A Nespolo; F Corridori; L La Mantia; C Milanese
Journal:  Ital J Neurol Sci       Date:  1987-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.